Home  |  Archive  |  Online Submission  |  News & Events  |  Subscribe  |  APFA  |  Society  |  Links  |  Contact Us  |  中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

Links

Meetings
Journals
Societies & Institutes
Hospitals
Databases & Libraries
Companies
Websites
Other links

 
Table of contents

Volume 20, Issue 2 (Mar 2018)

Review | Editorial | Original Article | Commentary | Letter to the Editor |

Testosterone and cardiovascular risk: good or bad?
(Guest editors: Prof. Bu B Yeap and Prof. Bradley D Anawalt)
See special issue articles marked

Editorial
Male Endocrinology
Why is understanding the relationship of testosterone to cardiovascular risk so important?
Bu B Yeap1,2, Bradley D Anawalt3
Asian J Androl 20: 107-108; 10.4103/aja.aja_71_17
Full Text | PDF [366] PDF [366]
Review
Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men
Bu B Yeap1,2
Asian J Androl 20: 109-114; 10.4103/aja.aja_50_17
Abstract | Full Text | PDF [177] PDF [177]
Endogenous testosterone and mortality risk
Emily J Meyer1,2, Gary Wittert1,2,3
Asian J Androl 20: 115-119; 10.4103/aja.aja_70_17
Abstract | Full Text | PDF [178] PDF [178]
Randomized controlled trials – mechanistic studies of testosterone and the cardiovascular system
T Hugh Jones1,2, Daniel M Kelly2,3
Asian J Androl 20: 120-130; 10.4103/aja.aja_6_18
Abstract | Full Text | PDF [167] PDF [167]
Trials of testosterone replacement reporting cardiovascular adverse events Thiago Gagliano-Jucá, Shehzad Basaria
Thiago Gagliano-Jucá, Shehzad Basaria
Asian J Androl 20: 131-137; DOI:10.4103/aja.aja_28_17
Abstract | Full Text | PDF [164] PDF [164]
Testosterone treatment and cardiovascular events in prescription database studies
Molly M Shores
Asian J Androl 20: 138-144; DOI:10.4103/aja.aja_25_17
Abstract | Full Text | PDF [167] PDF [167]
Would male hormonal contraceptives affect cardiovascular risk?
Michael Zitzmann
Asian J Androl 20: 145-148; 10.4103/aja.aja_2_18
Abstract | Full Text | PDF [176] PDF [176]
Commentary
Testosterone replacement therapy: Dilemmas and challenges in China and Asia
Qi An1,2, Yi-Qun Gu2
Asian J Androl 20: 149-151; 10.4103/aja.aja_16_17
Full Text | PDF [168] PDF [168]
Editorial
Conclusions about testosterone therapy and cardiovascular risk
Bradley D Anawalt1, Bu B Yeap2,3
Asian J Androl 20: 152-153; 10.4103/aja.aja_7_18
Full Text | PDF [179] PDF [179]
Original Article
Sperm Biology
The expression of the new epididymal luminal protein of PDZ domain containing 1 is decreased in asthenozoospermia
A-Juan Liang1,2, Gui-Shuan Wang3, Ping Ping1, Shuang-Gang Hu2, Yu Lin1, Yi Ma2, Zheng-Zheng Duan1, Han-Shu Wang1, Fei Sun1,3
Asian J Androl 20: 154-159; 10.4103/aja.aja_65_17
Abstract | Full Text | PDF [186] PDF [186]
Male Reproductive Health
An in vitro prototype of a porcine biomimetic testis-like cell culture system: a novel tool for the study of reassembled Sertoli and Leydig cells
Iva Arato1, Giovanni Luca1,2, Francesca Mancuso1, Catia Bellucci1, Cinzia Lilli1, Mario Calvitti1, Barbara C Hansen3, Domenico Milardi4, Giuseppe Grande4, Riccardo Calafiore2,5
Asian J Androl 20: 160-165; 10.4103/aja.aja_47_17
Abstract | Full Text | PDF [179] PDF [179]
Male sexual function/ED
Lipoxin A4 improves erectile dysfunction in rats with type I diabetes by inhibiting oxidative stress and corporal fibrosis
Kai Cui1,2, Zhe Tang1,2, Chuan-Chang Li1,2, Tao Wang1,2, Ke Rao1,2, Shao-Gang Wang1,2, Ji-Hong Liu1,2, Zhong Chen1,2
Asian J Androl 20: 166-172; 10.4103/aja.aja_49_17
Abstract | Full Text | PDF [182] PDF [182]
Prostate Disease
PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: evidence from patients in Northwestern China
Kai-Jie Wu, Xin-Qi Pei, Ge Tian, Da-Peng Wu, Jin-Hai Fan, Yu-Mei Jiang, Da-Lin He
Asian J Androl 20: 173-177; 10.4103/aja.aja_34_17
Abstract | Full Text | PDF [167] PDF [167]
Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion
Yao-An Wen1, Bo-Wei Zhou1, Dao-Jun Lv1, Fang-Peng Shu1, Xian-Lu Song2, Bin Huang1, Chong Wang1, Shan-Chao Zhao1
Asian J Androl 20: 178-183; 10.4103/aja.aja_57_17
Abstract | Full Text | PDF [160] PDF [160]
External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer
Yun-Jie Yang1,2, Guo-Wen Lin1,2, Gao-Xiang Li1,2, Bo Dai1,2, Ding-Wei Ye1,2, Jun-Long Wu1,2, Hu-Yang Xie1,2, Yao Zhu1,2
Asian J Androl 20: 184-188; 10.4103/aja.aja_39_17
Abstract | Full Text | PDF [170] PDF [170]
Operational Andrology
A retrospective review of single-institution outcomes with robotic-assisted microsurgical varicocelectomy
Andrew McCullough1, Leon Elebyjian2, Joseph Ellen3, Clay Mechlin4
Asian J Androl 20: 189-194; 10.4103/aja.aja_45_17
Abstract | Full Text | PDF [164] PDF [164]
Male Reproductive Health
Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia
Katherine Lang Rotker1, Michael Alavian1, Bethany Nelson1, Grayson L Baird2, Martin M Miner1, Mark Sigman1, Kathleen Hwang1
Asian J Androl 20: 195-199; 10.4103/aja.aja_51_17
Abstract | Full Text | PDF [169] PDF [169]
Prostate Disease
Andrographolide sensitizes prostate cancer cells to TRAIL-induced apoptosis
Ruo-Jing Wei, Xin-Shi Zhang, Da-Lin He
Asian J Androl 20: 200-204; 10.4103/aja.aja_30_17
Abstract | Full Text | PDF [161] PDF [161]
Letter to the Editor
Male Fertility
Diagnosis of a Chinese man with 45,X/46,X,i(Y)(q10)/47,X,i(Y) (q10) ×2 mosaic Turner syndrome
Yan-Wei Sha 1 , Lu Ding 1 , Zhi-Yong Ji 1 , Yun-Sheng Ge 2 , Hui Kong 2 , Qing Zhang 1 , Yu-Lin Zhou 2 , Ping Li 1
Asian J Androl 20: 205-207; 10.4103/1008-682X.193162
Full Text | PDF [168] PDF [168]
Fertility achieved through in vitro fertilization in a male patient with 48,XXYY syndrome
De-Feng Liu1, Lian-Ming Zhao2, Kai Hong2, Jia-Ming Mao1, Yu-Zhuo Yang1, Zhe Zhang2, Hui Jiang2
Asian J Androl 20: 208-209; 10.4103/aja.aja_44_17
Full Text | PDF [161] PDF [161]
Globozoospermic infertility associated with balanced DPY19L2 translocation/gene deletion at the chromosomal breakpoint
Yan-Wei Sha1, Li-Bin Mei1, Liang-Kai Zheng2, Rui-Hua Tian2, Lu Ding1, Zhi-Yong Ji1, Qing Zhang1, Ping Li1
Asian J Androl 20: 210-211; 10.4103/1008-682X.196314
Full Text | PDF [158] PDF [158]
Commentary
Operational Andrology
Commentary on “Nondegloving technique for Peyronie's disease with penile prosthesis implantation and double dorsal-ventral patch graft”
Gerard D Henry, Kavina Jani
Asian J Androl 20: 212-212; 10.4103/aja.aja_53_17
Full Text | PDF [165] PDF [165]
 
Copyright 1999-2017  Shanghai Materia Medica, Shanghai Jiao Tong University.  All rights reserved